Ramy Saleh, Kim N. Chi, Di Maria Jiang, Vincent Castonguay, Farzad Abbaspour, Ur Metser, Don Wilson, Junsheng Ma, Richard Cioci, Karim Nacerddine, Jean-Mathieu Beauregard. "ACCEL: [Ac-225]-PSMA-62 phase Ia/Ib/II clinical trial to characterize efficacy, safety, tolerability, and dosimetry in oligometastatic hormone-sensitive and metastatic castration-resistant prostate cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps282